Since launching in 2011, Silicon Valley healthcare startup Sano Intelligence has kept a low profile. Despite raising $US20 million ($26 million) in venture capital, the company founded by ex-Bain Capital analyst and bioengineering grad Ashwin Pushpala has yet to release its product — a continuous glucose tracker that sticks to a users' skin and monitors blood through an app. Gizmodo has obtained new details about the device, and how the company intends to market it as a product for "metabolic insight" for non-diabetics, rather than to diabetics who regularly need to track their glucose. The strategy means Sano doesn't need FDA approval in the US, but doctors and diabetes experts interviewed by Gizmodo question whether the product would have any benefits to non-diabetics at all.
Tagged With diabetes
A Harvard research team led by biologist Douglas Melton has retracted a promising research paper following multiple failed attempts to reproduce the original findings.
Australian scientists have shown that brown fat — a special type of fat that burns energy to produce heat — may also help to keep blood sugar steady in adults. Researchers at Sydney’s Garvan Institute of Medical Research measured brown fat activity and blood glucose continuously in real time in study participants, and found that individuals with more brown fat had smaller fluctuations in blood sugar.
Their findings open new avenues for diabetes therapies that target brown fat.
Adelaide researchers have developed a diet and exercise program which has proven to be highly effective in reducing the burden of type 2 diabetes, with an average 40 per cent reduction in medication levels. The diet incorporates an eating pattern that is very low in carbohydrates and higher in protein and unsaturated fats.
With Apple Watch quickly approaching its April release month, app developers are giving us a better sense of the wearable's capabilities than the designers at Cupertino. For instance, we know how the watch will work with your car or draw up a to do list. Now its health merits are getting some attention.
Stanford researchers recently published work on a small microchip they have developed that scans for diabetes in a fraction of the time of current tests. Additionally, their test is reusable for upwards of 15 patients, can be performed on site, and is more accurate in differentiating the biomarkers that distinguish type 1 and type 2 diabetes. In other words, it's a major milestone in diabetes research.
As if all the side effects and health concerns related to diabetes weren't enough, those dealing with the condition also have to maintain a frequent and carefully tracked regiment of insulin injections. Missing even one can be incredibly dangerous, which is what inspired one company to create the Timesulin.